What is the total market size of the lithium therapy treatment market in 2018?

The total market value of lithium therapy treatment in was USD 103.9 Million in 2018. Read More

What is the forecast period in the market report?

The forecast period in the market is 2019-2027. REQUEST FREE SAMPLE

Which is base year calculated in the lithium therapy treatment market?

The base year calculated in the report is 2018. Read More

What is the estimated growth rate of the Asia Pacific region?

The growth rate of the Asia Pacific region is estimated to be 3.5% in the forecast period. Read More

Which region holds the largest market share of the lithium therapy treatment market?

North America held the largest market share in 2018 and is likely to maintain its dominance throughout the forecast period. Read More

Lithium Therapy Market Size, Share, Growth and Forecast to 2027

Get Report Summary

Market Snapshot

CAGR:2.30

2018

2027

Source: Reports and data

Study Period	2016-2027
Base Year	2018
CAGR	2.30

Gain accurate insights regarding the negative impacts of COVID-19 on all markets and industries

Download Sample Pdf

Market Summary

The lithium therapy market is projected to grow at a rate of 2.3% in terms of value, from 2019 to reach USD 128.6 Million by 2027. Lithium Therapy is used as an antipsychotic drug for treating bipolar disorder. Sometimes, it may be utilized in other disorders to supplement an antidepressant that is unable to treat depression effectively.

The growing geriatric population is likely to boost the market demand in the forecast period. As per the Global Health and Aging report published by the WHO (World Health Organization), the number of people aged 65 years or older is estimated to increase from a projected 524 million in 2010 to approximately 1.5 billion by 2050, with a significant percentage of increase in developing economies. Additionally, the number of people aged 65 years or older is anticipated to considerably surpass children younger than five years of age by 2050. Aging leads to the deterioration of facet joints resulting in several spinal disorders. Thus, the increasing prevalence of diseases in the growing geriatric population is likely to propel the growth of the market in the forecast period.

According to a study, bipolar disorder exists in 6.0% of geriatric outpatient appointments, 8.0%–10.0% of geriatric inpatient admissions, 3.0% of geriatric people admitted in nursing homes, and 17% of geriatric patients referred to psychiatric emergency departments. Hence, the worldwide rise in the aging population will be directly proportional to the number of elderly people with the condition.

The market in the Asia Pacific region is estimated to witness the fastest growth rate in the forecast period, due to the improving healthcare infrastructure, rising investments, and better reimbursement scenario.

Key Coverage of the Report

Region and country wise statistics of lithium therapy from the period 2016-2027. While 2016 & 2017 have been utilized as historical data, 2018 is considered the base year. 2019-2026 have been derived as forecasts.
Estimation of the market size along with historic and forecasted trend analysis
Various types of dosage forms have been analyzed. Statistical analysis has been conducted on obtaining the individual share of these segments.
The share of individual distribution channels has been estimated.
Healthcare Regulatory framework of each region
Regional up-coming drugs and therapies outlook
Status of on-going clinical trials and developments
The regional prevalence of lithium therapy has been mapped.
Regional Competitors Pricing Strategy
Demand and Supply GAP Analysis
Market share analysis of the top industry players
Strategic recommendations for the new entrants
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments.

lithium-therapy-market-type-outlook

Salient Trends of the Lithium Therapy Market

Approximately 3.0% of lithium produced across the globe has applications in the healthcare sector.
When used in combination, lithium enhances the efficacy of multiple agents in the severe and long-term therapy of bipolar disorder. These drugs comprise carbamazepine, valproate, nimodipine, lamotrigine, and most of the atypical Antipsychotics.
Patients on lithium therapy are also required to have the lithium-ion monitored in their blood to ascertain that it’s below toxic levels. Some of the side-effects of lithium toxicity include tremors, thyroid problems, frequent urination, weight gain, and, in some cases, renal malfunctioning.
In 2016, lithium was the 222^nd most prescribed therapy in the U.S. with over two million prescriptions.
Lithium salts have shown potential effectiveness in treating Alzheimer’s disease. The World Health Organization (WHO) has estimated that the number of dementia cases will increase almost two-fold by the year 2030 and three-fold by 2050. In the U.S., the most common form of dementia, Alzheimer’s disease, is the sixth-most leading cause of death. One in three older adults dies owing to this kind type of memory loss.
Lithium carbonate is the most common type of lithium salt used in lithium therapy.
In 2017, in the U.S., the number of lithium prescriptions was 3,358,268.

Companies considered and profiled in this market study

Pfizer, Alkem, Sun Pharma, Apotek Corp., Glenmark Generics, Intas, Taurus Labs, GlaxoSmithKline, Noven Pharmaceuticals, and Cardinal Health, among others.

Market-O-Nomics

The valuation for the lithium therapy market was USD 103.9 Million in 2018, and it is expected to reach USD 128.6 Million by 2027.
By product type, generic products are likely to grow at a faster rate in the forecast period. Generic drug therapies substitutes are an FDA-approved and effective alternative for patients. Such mediation is similar to the branded drugs in several categories, such as dosage, quality, intended use, strength, safety, and performance characteristics. As per the Food & Drug Administration (FDA), generic drugs may cost around 85.0% less than the drugs they are designed to replicate.
By dosage form, the solution contributed to a significant market share in 2018.
By distribution channel, online-retail pharmacies are estimated to witness the fastest growth rate in the forecast period.
North America dominated the market in 2018 and is expected to grow at a rate of 1.9% in the forecast period. The market dominance is owing to the higher acceptance of advanced technologies, well-established healthcare facilities, and the presence of leading market players in the region.
Europe is likely to observe a growth rate of 2.1% in the period 2018-2019.

Segments covered in the report:

This report forecasts revenue growth at a global, regional & country level and provides an analysis on the industry trends in each of the sub-segments from 2016 to 2027. For the purpose of this study, Reports and Data have segmented the global lithium therapy market on the basis of product type, dosage form, distribution channel, and region: